Preclinical evaluation of BAY 16-9966 a dual IL-4/IL-13 receptor antagonist

被引：0
|
作者：
Fitch, N [1 ]
Morton, M [1 ]
Bowden, A [1 ]
Shanafelt, MC [1 ]
Shanafelt, A [1 ]
Wetzel, G [1 ]
Moy, J [1 ]
机构：
[1] Bayer Corp, Biotechnol Res, Berkeley, CA USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2001年 / 107卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
209
引用
收藏
页码：S61 / S61
页数：1
相关论文
共 50 条
  • [1] Role of periostin, FENO, IL-13, lebrikzumab, other IL-13 antagonist and dual IL-4/IL-13 antagonist in asthma
    Agrawal, Swati
    Townley, Robert G.
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (02) : 165 - 181
  • [2] IL-4 receptor α polymorphisms are predictors of a pharmacogenetic response to a novel IL-4/IL-13 antagonist
    Slager, Rebecca E.
    Hawkins, Gregory A.
    Ampleford, Elizabeth J.
    Bowden, Alexandra
    Stevens, Lauren E.
    Morton, Matthew T.
    Tomkinson, Adrian
    Wenzel, Sally E.
    Longphre, Malinda
    Bleecker, Eugene R.
    Meyers, Deborah A.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 126 (04) : 875 - 878
  • [3] Pitrakinra, a dual IL-4/IL-13 antagonist for the potential treatment of asthma and eczema
    Antoniu, Sabina A.
    [J]. CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2010, 11 (11) : 1286 - 1294
  • [4] The evolution of IL-4 and IL-13 and their receptor subunits
    Wang, Tiehui
    Secombes, Christopher J.
    [J]. CYTOKINE, 2015, 75 (01) : 8 - 13
  • [5] Distinct roles for IL-13 and IL-4 via IL-13 receptor α1 and the type II IL-4 receptor in asthma pathogenesis
    Munitz, A.
    Brandt, E. B.
    Mingler, M.
    Finkelmant, F. D.
    Rothenberg, M. E.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (20) : 7240 - 7245
  • [6] Development and preclinical evaluation of a vaccine targeting IL-4 and IL-13 for the treatment of allergic asthma
    Conde, Eva
    Bruhns, Pierre
    Serra, Vincent
    Reber, Laurent L.
    [J]. ALLERGY, 2021, 76 (11) : 3553 - 3555
  • [7] Inhaled vs subcutaneous effects of a dual IL-4/IL-13 antagonist in a monkey model of asthma
    Tomkinson, A.
    Tepper, J.
    Morton, M.
    Bowden, A.
    Stevens, L.
    Harris, P.
    Lindell, D.
    Fitch, N.
    Gundel, R.
    Getz, E. B.
    [J]. ALLERGY, 2010, 65 (01) : 69 - 77
  • [8] Drugmakers cling to dual IL-13/IL-4 blockbuster hopes
    Sheridan, Cormac
    [J]. NATURE BIOTECHNOLOGY, 2018, 36 (01) : 3 - 5
  • [9] Drugmakers cling to dual IL-13/IL-4 blockbuster hopes
    Cormac Sheridan
    [J]. Nature Biotechnology, 2018, 36 : 3 - 5
  • [10] IL-13 receptor α 2:: A regulator of IL-13 and IL-4 signal transduction in primary human fibroblasts
    Andrews, Allison-Lynn
    Nasir, Tosia
    Bucchieri, Fabio
    Holloway, John W.
    Holgate, Stephen T.
    Davies, Donna E.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 118 (04) : 858 - 865
12345